Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta by Fortuño, A. (Ana) et al.
Leptin Inhibits Angiotensin II-Induced Intracellular
Calcium Increase and Vasoconstriction in the Rat Aorta
ANA FORTUN˜O, AMAIA RODRı´GUEZ, JAVIER GO´MEZ-AMBROSI, PAULA MUN˜IZ,
JAVIER SALVADOR, JAVIER Dı´EZ, AND GEMA FRU¨HBECK
Division of Cardiovascular Pathophysiology (A.F., P.M., J.D.) and Metabolic Research Laboratory (A.R., J.G.-A., G.F.),
University of Navarra School of Medicine, and Departments of Endocrinology (J.S., G.F.) and Cardiology and
Cardiovascular Surgery (J.D.), Clı´nica Universitaria de Navarra, 31008 Pamplona, Spain
Besides its role in body weight control leptin may also act as
a vasoactive hormone. This study was designed to investigate
whether leptin modifies angiotensin II (ANG II)-induced vas-
cular responses. The expression of functional leptin receptors
(OB-Rb) was detected in vascular smooth muscle cells
(VSMCs) from adult Wistar rats by RT-PCR. Immunocyto-
chemistry and Western blot analysis further showed the ex-
pression of OB-R protein in VSMCs. The ANG II (107 mol/
liter)-induced increase in intracellular Ca2was blocked (P <
0.01) by leptin (108 mol/liter). Moreover, in calcium-free
buffer leptin was able to inhibit 65% of the ANG II-induced
calcium release from intracellular stores. In endothelium-
denuded aortic rings from adult Wistar rats no effect of leptin
on basal tension was observed. However, the ANG II-induced
isometric contraction was reduced (P < 0.05) by leptin (108
mol/liter). The experiments were also performed in age- and
sex-matched Zucker rats, in which no effect of leptin on ANG
II-induced calcium increase and vasoconstriction was ob-
served. It is concluded that leptin blocks the vasoconstrictor
action of ANG II and inhibits the ANG II-induced increase in
intracellular Ca2 in VSMCs through OB-Rb. These findings
provide new insight into the physiological effects of leptin on
blood pressure regulation. (Endocrinology 143: 3555–3560,
2002)
OBESITY IS an important risk factor for the developmentof vascular disorders such as hypertension (1, 2). The
ob gene product, leptin (3), is a peptidic hormone produced
mainly by adipose tissue that acts as a signaling mechanism
to regulate body fat content (4) through binding to leptin
receptors located in hypothalamic nuclei (5). In recent years
the potential participation of leptin on blood pressure ho-
meostasis has been investigated. Chronic high dose admin-
istration of leptin has been reported to increase arterial pres-
sure and heart rate in conscious rats by peripherally or
centrally mediated mechanisms (6, 7). The presence of func-
tional leptin receptors (OB-Rb) in endothelial cells provides
a new target for leptin action, namely the vascular wall.
Leptin induces direct vasodilation through distinct endothe-
lial mechanisms (8) that oppose the sympathetic-mediated
pressor response (9). Besides, our group had previously
shown that leptin induces the release of nitric oxide (NO) at
the same time as it triggers sympathoexcitation (10). Thus,
leptin seems to exert dual effects on the regulation of vascular
tone.
The vasoactive peptide angiotensin II (ANG II) is an im-
portant factor regulating blood pressure (11). Alterations in
the synthesis of and responsiveness to ANG II have been
implicated in the pathophysiology of arterial hypertension
(12). In addition, Barton et al. (13) found that obesity is as-
sociated with activation of the renin-angiotensin system in
nonadipose tissue. Besides, an adipose tissue-specific in-
crease in the production of angiotensinogen during the onset
of obesity has recently been reported (14). According to pre-
vious studies, the link between angiotensinogen production
and the control of adipose mass involves ANG II, which has
been implicated in the differentiation of adipose precursors
by paracrine/autocrine mechanisms (15). Therefore, the
present study explored the possibility that leptin might in-
terfere with the vascular responses induced by ANG II
through OB-Rb. To test this hypothesis, the in vitro effects of
leptin on both ANG II-induced increases in the intracellular
free calcium concentration ([Ca2]i) transients in vascular
smooth muscle cells (VSMCs) and isometric contraction of
endothelium-denuded and intact aortic rings from Wistar
rats as well as leptin receptor-deficient obese Zucker rats
were assessed. In addition, the expression of OB-Rb in
VSMCs from Wistar rats was investigated.
Materials and Methods
Animals
Ten-week-old male Wistar rats (breading house of University of Na-
varra) and obese Zucker fa/fa rats (Harlan, Barcelona, Spain) were used
in the study. Rats were maintained under controlled conditions of room
temperature (20 2 C), relative humidity (50 10%), ventilation (at least
15 complete changes of air/h), and artificial light-dark cycle (lights on
from 0800–2000 h). Animals had free access to tap water and were fed
ad libitum an isoenergetic (13.39 MJ/kg), isoproteic (14%) rodent main-
tenance diet containing 0.13% sodium (2014S Teklad Global 14% Protein
Rodent Maintenance Diet, Harlan, Barcelona, Spain). The investigation
was performed according to the European Community Guidelines for
animal ethical care and use of laboratory animals (Directive 86/609) and
was approved by the local ethical committee (011/99; 001/01). Rats were
killed by decapitation. The thoracic aorta was carefully excised, dis-
sected out, and processed for each study.
Cell isolation and culture
Primary VSMCs were obtained from the thoracic aorta of Wistar and
Zucker rats and cultured by the tissue explants method in accordance
Abbreviations: ANG II, Angiotensin II; [Ca2]i, intracellular free cal-
cium concentration; NA, noradrenaline; NO, nitric oxide; VSMC, vas-
cular smooth muscle cell.
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with previously published procedures (16). The culture was continued
up to eight passages using 5% fetal bovine serum with an antibiotic-
antimicotic product (Life Technologies, Inc., Gaithersburg, MD; 10,000
U/ml penicillin G sodium, 10,000 g/ml streptomycin sulfate, and 25
g/ml amphotericin B as Fungizone in 0.85% saline). Immunocyto-
chemical characterization of isolated VSMCs was performed on primary
cultures, using specific antibodies against smooth muscle-specific
-actin (DAKO Corp., High Wycombe, UK). VSMCs were differently
processed depending on the study protocol.
Detection of leptin receptors in VSMCs
Total RNA was extracted in TRIzol reagent (Life Technologies, Inc.)
from a 75-mm2 flask of VSMCs, according to the manufacturer’s in-
structions. The yield and quality of the RNA were assessed by measuring
absorbance at 260 and 280 nm and by electrophoresis on 1.5% agarose
gels. One microgram of RNA was used to synthesize first strand cDNA
after treatment for 60 min at 37 C with 10 U ribonuclease-free deoxyri-
bonuclease I (Roche Molecular Biochemicals, Mannheim, Germany). The
RT reaction was carried out in a volume of 20 l containing 50 mmol/
liter Tris-HCl (pH 8.3), 75 mmol/liter KCl, 3 mmol/liter MgCl2, 10
mmol/liter dithiothreitol, 100 ng random hexamers (Roche Molecular
Biochemicals), 1 mmol/liter of each deoxy-NTP (Bioline, London, UK),
20 U ribonuclease inhibitor (Promega Corp., Madison, WI), and 200 U
Moloney murine leukemia virus reverse transcriptase (Life Technolo-
gies, Inc.) and incubated at 37 C for 60 min. The enzyme was inactivated
by heating at 95 C for 5 min. Four microliters from the RT reaction were
amplified in a 50-l reaction mixture containing 40 ng of each primer,
16 mmol/liter (NH4)2SO4, 67 mmol/liter Tris-HCl (pH 8.8), 2 mmol/liter
MgCl2, 0.1% Tween 20, 0.2 mmol/liter of each deoxy-NTP, and 1 U
BIOTAQ polymerase (Bioline). Primers used to amplify rat OB-Ra and
OB-Rb cDNA were a common forward primer (5-ACACTGTTAATT-
TCACACCAGAG-3) used in combination with a specific reverse
primer either for the short (a) form (5-AGTCATTCAAACCATAGTT-
TAGG-3) or the long (b) form (5-TTCCAAAAGCTCATCCAACCC-3).
As a control, mock amplifications were carried out in the presence of
RNA template and Taq polymerase, but in the absence of reverse tran-
scriptase. As a control for RNA quality and quantity, -actin mRNA was
amplified from all RNA samples using primers 5-TCTACAATGAGCT-
GCGTGTG-3 and 5-GGTCAGGATCTTCATGAGGT-3, based upon
the sequence of rat -actin. cDNA was amplified for 40 (OB-Ra), 45
(OB-Rb), and 35 cycles (-actin) using the following parameters: 94 C for
30 sec, 55 C (OB-Ra and OB-Rb) and 59 C (-actin) for 30 sec, and 72 C
for 30 sec, with a final extension step at 72 C for 7 min. Amplifications
were carried out in a GeneAmp PCR System 2400 (Perkin-Elmer, Nor-
walk, CT). The amplified products were resolved in a 1.5% agarose gel
with ethidium bromide. Images were captured with the Gel Doc 1000 UV
fluorescent gel documentation system and Molecular Analyst 1.4.1 soft-
ware (Bio-Rad Laboratories, Inc., Hercules, CA).
VSMCs from the aortas of Wistar rats were homogenized in ice-cold
lysis buffer containing sacarose (0.32 mol/liter) and protease inhibitor
cocktail (Roche). The protein content of the crude preparations was
measured by the Bradford method (17), using lyophilized BSA (Bio-Rad
Laboratories, Inc.) as standard. Equal amounts of proteins (30 g) were
run out in 8–12% SDS-PAGE, subsequently transferred to nitrocellulose
membranes (Amersham Pharmacia Biotech, Little Chalfont, UK) by
electrotransfer, and blocked in 4% Tris-buffered saline-Tween 20 for 60
min at room temperature under agitation. The membranes were incu-
bated overnight at 4 C under agitation with an N-terminal polyclonal
antibody against OB-R (1:500) in 4% Tris-buffered saline-Tween 20. The
antigen-antibody complexes were visualized using peroxidase-conju-
gated antigoat IgG antibody (1:10,000) and the enhanced chemilumi-
nescence ECL detection system (Amersham Pharmacia Biotech).
The presence of OB-R immunoreactivity on intact VSMCs was stud-
ied by immunocytochemistry. Cells were grown on four-well plates,
fixed with 4% paraformaldehyde, and washed with cold PBS. Fixed cells
were treated with 5% dimethylsulfoxide and 0.25% Triton X-100 solu-
tion. After blocking with 4% fetal bovine serum for 1 h, cells were
incubated overnight at 4 C with rat polyclonal antiserum specific for the
N-terminal region of OB-R (1:100). After washing three times, cells were
incubated with biotinylated goat antirat IgG antibody (1:100) in PBS for
1 h, washed, and reacted with avidin-fluorescein isothiocyanate conju-
gate (1:100; Sigma, St. Louis, MO) for 30 min. Finally, VSMCs were
mounted in synthetic resin with 4,6-diamidino-2-phenylindole. All an-
tibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA).
Measurement of [Ca2]i in VSMCs
Measurement of [Ca2]i was performed as previously described (16).
Briefly, nonconfluent cultures of VSMCs grown on round 22-mm cov-
erslips were incubated in a humidified incubator for 45 min with fura-
2/AM (4–7 mol/liter) dissolved in dimethylsulfoxide with 0.02% plu-
ronic acid. Fura-2-loaded VSMCs were placed in a thermostatically
perfusion chamber on top of the stage of an inverted microscope
equipped for epifluorescence (Diaphot, Nikon, Badhoevedorp, The
Netherlands) and attached to an image analysis system (Magiscal Ap-
plied Imaging, Newcastle upon Tyne, UK). Upon binding Ca2, fura-2
exhibits an absorption shift from 340 to 380 nm that can be monitored
by measuring the emission at 510 nm. The [Ca2]i was calculated as
described by Grynkiewicz et al. (18).
Preparation of isolated aortic rings
The thoracic aorta was removed immediately after sacrifice, cleaned,
and placed into Krebs-Heinseleit solution as previously described (16).
The endothelium of the aorta was removed by gently rubbing the intimal
surface with the tip of a small steel stick. In some experiments the
endothelium of the aorta was preserved to analyze the effect of leptin
on intact aortic rings. Both intact and endothelium-denuded rings were
incubated for 60 min to equilibrate at a resting tension of 2.5 g, with
buffer changes every 15 min to reach equilibrium conditions. The lack
of a functional endothelium was confirmed by demonstrating the com-
plete absence of relaxation induced by acetylcholine (105 mol/liter) in
80 mm KCl-precontracted aortic rings. The rings were then washed and
stretched if necessary until a stable baseline force was obtained. The
contraction with KCl was also used to test the contractile response of the
tissue.
Study of vasoactive responses
Cumulative concentration-response curves to 109–106 mol/liter
ANG II were obtained to determine the concentration needed for sub-
maximal effects and the pD2 value. In a second group of experiments,
VSMCs or aortic rings were previously incubated with different con-
centrations of leptin (1010–107 mol/liter) before testing the ANG
II-induced response. To study the specificity of the inhibitory effect of
leptin on ANG II-mediated actions the response to another vasoactive
substance was further tested. As leptin has been shown to induce a
sympathoexcitation (1, 7, 19–21), and the sympathetic nerve activity
represents one of the most important factors controlling ongoing vaso-
constriction, the effect of leptin on the noradrenaline (NA; 107 mol/
liter)-induced contractile response was examined. One sample per ex-
periment was used to obtain control responses (100%) in the presence
of the solvent. Repetitive use of experimental products on the same
aortic ring preparations was avoided to stay clear of possible
desensitization.
Statistical analysis
Values are given as the mean  sem. Statistical differences between
mean values were determined using one-way ANOVA, followed by
Dunnett’s t test. When the number of determinations were less than 10,
statistical analysis was performed using the nonparametric Kruskal-
Wallis test. P  0.05 was considered statistically significant. Concen-
tration-response curves were fitted by nonlinear regression, the con-
centration giving 50% of the maximal response (EC50) was determined,
and the pD2 was calculated as log EC50 (mol/liter).
Results
Expression of leptin receptors in VSMCs
RT-PCR was used to detect mRNAs of the short (OB-Ra)
and full-length (OB-Rb) isoforms in RNA isolated from con-
fluent cultures of VSMCs from Wistar rats (Fig. 1A). The
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receptor splice variants OB-Ra and OB-Rb were expressed in
VSMCs, as demonstrated by PCR products of 237 and 612 bp,
respectively. The easy detection of OB-R expression confirms
the vascular smooth muscle as a potential target for leptin
action.
The presence of the OB-R protein in VSMCs from Wistar
rats was evaluated by Western blot and immunocytochem-
ical analysis. As shown in Fig. 1B, a 130-kDa band was found
in all experiments performed (n 12). Due to the N-terminal
nature of the polyclonal antibody used against OB-R, four
additional bands of lower molecular weights were also ob-
served. No immunoreactivity was found without the pri-
mary antibody (data not shown). The immunocytochemical
analysis of the cellular distribution of OB-R indicates that all
VSMCs were immunopositive, exhibiting a whole-cell stain-
ing pattern (Fig. 1C).
Effects of leptin on ANG II-induced [Ca2]i responses
in VSMCs
In the presence of 1.3 mmol/liter Ca2 in the bathing
medium, ANG II increased [Ca2]i in VSMCs from Wistar
rats in a concentration-dependent manner (pD2  8.6 0.6).
A concentration of 107 mol/liter ANG II, inducing a re-
sponse of 728.2  51.1 nmol/liter (basal [Ca2]i, 64.8  9.3
nmol/liter), was chosen for subsequent experiments.
Although no basal effects of leptin on [Ca2]i in VSMCs
were observed (data not shown), all leptin concentrations
tested inhibited (P  0.01) ANG II-induced [Ca2]i stimula-
tion in VSMCs from Wistar rats (Fig. 2A). The inhibitory
FIG. 1. A, mRNA expression of the long (OB-Rb) and short (OB-Ra)
leptin receptor mRNA isoforms in VSMCs. DNA was amplified from
first strand cDNA synthesized from total RNA in presence () or
absence () of reverse transcriptase. The lengths of the RT-PCR
products correspond to the sizes predicted from the nucleotide se-
quences encoding OB-Rb (612 bp), OB-Ra (237 bp), and -actin (314
bp). B, Western blot analysis of leptin receptor (OB-R) in VSMCs of
Wistar rats is shown using duplicate sample preparations and incu-
bated with a polyclonal antibody against OB-R. A mayor band of
120–130 kDa was detected in all experiments performed (n  12).
Sizes corresponding to molecular weight markers are indicated. C,
Immunocytochemical identification of OB-R in cultured VSMCs from
rat aorta. In the left panel, VSMCs are visualized with an optic
microscope. In the right panel, the same microscopic field is visualized
with a fluorescence filter for fluorescein isothiocyanate. Most cells are
immunopositive, with a whole cell pattern of staining. Representative
pictures from six experiments are shown. Original magnification,
200.
FIG. 2. A, The bar graph shows the ANG II (107 mol/liter)-induced
changes in [Ca2]i in absence of or after incubation for 30 min of
VSMCs from adult Wistar rats with different concentrations of leptin.
B, Representative line graphs showing the differences in the time
course of the ANG II-induced [Ca2]i increase in the absence (E) and
presence (F) of 108 mol/liter leptin. Maximal stimulated [Ca2]i
occurred at 1–3 sec, and the recovery time to basal concentrations was
measured thereafter. Values are the mean  SEM from 10–15 deter-
minations/concentration. *, P 0.05; **, P 0.01; ***, P 0.001 (vs.
curve obtained in the absence of leptin).
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effect was independent of cell passage. VSMCs exposed to
ANG II showed a rapid rise in [Ca2]i that reached a max-
imum in 10 sec, declined rapidly within 30–40 sec, and then
gradually decreased in the next 1–2 min to near-resting val-
ues (Fig. 2B). In the presence of leptin (108 mol/liter) the
maximum value reached was inhibited by approximately
75% (Fig. 2B).
In Ca2-free medium the ANG II (107 mol/liter) response
was 574.3  96.6 nmol/liter, representing 71  12% of the
ANG II response in the presence of extracellular calcium.
Leptin (108 mol/liter) inhibited (P 0.01) by 65% the ANG
II (107 mol/liter)-induced increase in [Ca2]i in VSMCs
from Wistar rats (Fig. 3A). However, the same leptin con-
centration was not able to inhibit ANG II (107 mol/liter)-
induced [Ca2]i stimulation in VSMCs obtained from Zucker
rats (Fig. 3B).
Effects of leptin on the response induced by vasoactive
agonists in aortic rings
ANG II elicited a concentration-dependent increase in the
vascular tone of aortic rings of Wistar rats (pD2  8.3 0.6).
On the basis of this concentration-response curve, a concen-
tration of 107 mol/liter was chosen to carry out the next
experiments. No basal effect of leptin on endothelium-
denuded aortic rings from Wistar rats was observed (data not
shown). However, the ANG II (107 mol/liter)-induced va-
soconstriction was inhibited (P  0.05) by leptin at 108
mol/liter (Fig. 4A). No inhibitory effect of leptin was ob-
served on ANG II-induced vasoconstriction in endothelium-
denuded aortic rings from Zucker rats (Fig. 4B).
To further analyze the physiological significance of lep-
tin on ANG II-induced vasoconstriction, the effects of lep-
tin were examined in intact vessels. In intact aortic rings,
leptin (108 mol/liter) produced a significant (P  0.029)
decrease in passive wall tension (23.1  2.4 vs. 12.5 
2.7 mg) that was not observed in endothelium-denuded
rings. Contrary to what was observed in endothelium-
denuded preparations, no effect of leptin on ANG II-in-
duced vasoconstriction was evident in intact aortic rings
(Fig. 4A).
Finally, to test the specificity of the inhibitory effect of
leptin on ANG II, the response to a well known vasoactive
substance such as NA was also studied. As expected in both
intact and endothelium-denuded aortic rings, NA (107
mol/liter) produced a statistically significant (P  0.001)
vasoconstriction. As shown in Fig. 5, no significant effect of
leptin (108 mol/liter) on the NA-induced contractile re-
sponse was observed in either intact or endothelium-
denuded aortic rings.
FIG. 3. A, Inhibitory effect of 108 mol/liter leptin on ANG II (107
mol/liter)-induced response of VSMCs from Wistar rats in the absence
of calcium in extracellular medium. B, Effect of 108 mol/liter leptin
on ANG II-induced response of VSMCs obtained from obese Zucker
rats. Values are the mean  SEM from seven to nine determinations.
**, P  0.01 vs. control response to ANG II.
FIG. 4. A, Response to ANG II (107 mol/liter)-induced vasoconstric-
tion of intact () and endothelium-denuded (f) aortic rings in the
absence of or after preincubation for 30 min with leptin (108 mol/
liter). B, Histograms showing the ANG II (107 mol/liter)-induced
changes in tension of endothelium-denuded aortic rings from adult
obese Zucker rats in the absence or presence of leptin (108 mol/liter).
Values are the mean  SEM from at least 10 determinations/concen-
tration. **, P  0.01 vs. control response.
FIG. 5. Response to NA (107 mol/liter)-induced vasoconstriction of
intact () and endothelium-denuded aortic rings (f) in the absence
of or after preincubation for 30 min with leptin (108 mol/liter). Values
are the mean  SEM from at least 10 determinations/concentration.
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Discussion
In addition to its ability to stimulate sympathetic mecha-
nisms that result in vasoconstriction (1, 7, 19–21), several
vascular actions of leptin implying vasodilation have been
described. Fru¨hbeck (10) demonstrated in rats with auto-
nomic blockade that leptin infusion induced a systemic va-
sodilation that was associated with an increase in serum
NO3-NO2 concentrations. Interestingly, leptin-induced va-
sodilation was reversed by N-nitro-l-arginine methyl ester
administration. On the other hand, leptin has been shown to
induce a clear vasodilation in both aortic and mesenteric
arteries, which is abolished by endothelial denudation, sug-
gesting that endothelium integrity is critical for leptin’s vas-
cular relaxing action (8). Furthermore, functional leptin re-
ceptors have been identified in endothelial cells (22–24).
Therefore, leptin seems to be able to stimulate endothelial
NO-mediated vasodilation, although this fact has been ques-
tioned by Mitchell et al. (25) using the same physiological
leptin concentrations as other research groups. Further sup-
port of the NO-mediated leptin actions has been provided by
Vecchione et al. (26), showing that the effect of leptin on
endothelial NO is mediated through the Akt-endothelial
NOS phosphorylation pathway. The vasodilator effect has
been shown to be dependent on the presence of the endo-
thelium. Moreover, findings reported in the present study
suggest that VSMCs may represent a target for the vasodi-
lation actions of leptin by opposing ANG II-induced effects
leading to vasoconstriction.
The present study confirms that functional leptin receptors
are expressed in VSMCs of Wistar rats. The band detected
with a molecular mass of approximately 120–130 kDa prob-
ably corresponds to OB-Rb, which has been previously de-
scribed in other animal and human cell types (27–29). This
finding supports recent evidence of the expression of func-
tional leptin receptors in calcifying vascular cells (30) and
aortic smooth muscle cells (31). Together these results sup-
port the hypothesis that leptin plays a relevant role in mod-
ulating vasoregulatory function directly through OB-Rb on
the vascular wall. Due to the fact that the antibody used to
detect OB-R expression in Western blot analysis is raised
against the N-terminal region, common to all five isoforms
of the receptor, four additional bands of lower molecular
weights, probably representing the different receptor iso-
forms, were also identified in VSMCs (32). The possibility
that OB-Rb is functional in VSMCs is supported by other
findings reported herein: 1) physiological concentrations of
leptin block the ANG II-induced rapid increase in [Ca2]i in
cultured VSMCs of the aorta from Wistar rats; 2) leptin in-
hibits the ANG II-induced fast contraction in endothelium-
denuded aortic rings from Wistar rats; and 3) no effects of
leptin were found in the aorta and VSMCs obtained from
Zucker rats with a mutation in the leptin receptor gene that
results in the loss of its functional activity.
Central to the direct vasoconstrictor action of ANG II on
smooth muscle is its capacity to increase [Ca2]i. After the
interaction with the AT1 receptor, ANG II mobilizes Ca
2 by
releasing Ca2 sequestered intracellularly and by increasing
Ca2 influx from the extracellular compartment. The former
event may occur via phosphoinositide turnover, and the
latter in association with voltage-sensitive Ca2 channels (11,
33). As a consequence, [Ca2]i increases and VSMC contrac-
tion ensue. Our finding that leptin retains the ability to in-
hibit ANG II-mediated stimulation of VSMC [Ca2]i in Ca
2-
free medium strongly suggests that the hormone blocks the
ANG II-induced release of Ca2 from the intracellular stores.
Takekoshi et al. (34, 35) reported recently that leptin induces
increases in cAMP levels in cultured porcine adrenal med-
ullary chromaffin cells. As cAMP facilitates Ca2 sequestra-
tion by the sarcoplasmic reticulum (36), we speculate that
cAMP may mediate the ability of leptin to inhibit ANG
II-induced stimulation of intracellular Ca2 stores in VSMCs.
Further studies are required to elucidate the ability of leptin
to stimulate cAMP in these cells.
To improve our understanding of the physiological sig-
nificance of leptin on ANG II-induced vasoconstriction, the
effects were tested not only in denuded aortic rings, but also
in intact vessels. Contrary to what was observed in endo-
thelium-denuded preparations, in intact aortic rings no effect
of leptin on ANG II-induced vasoconstriction was observed.
Several plausible explanations may underlie this finding.
Leptin may simultaneously induce the release of other va-
soactive substances, with either a direct or indirect effect on
the vascular tone of the ring. It is well known that the va-
soconstrictor effect elicited by ANG II has a 2-fold compo-
nent, a direct and an indirect effect, depending on the release
of further endothelium-derived factors with a vasoconstric-
tor effect such as endothelin-1 (37). In addition, the incuba-
tion period used in our experiments was 30 min, and during
this period the endothelium was exposed to the plentiful
release of vasoactive factors such as NO and endothelin-1,
among others. In fact, recombinant leptin has been shown to
induce a slight decrease in passive wall tension (8). We have
confirmed this finding in our study, showing that in intact
aortic rings leptin produced a significant decrease in passive
wall tension that was not observed in endothelium-denuded
rings. The different molecular weights of ANG II and leptin
(1 vs. 16 kDa, respectively) may also be responsible for the
different transport possibilities and, consequently, the dif-
ferent abilities to reach the layer of VSMCs. Interestingly, it
has been recently reported that leptin released by the fat
depot produces a dose-dependent increase in plasma NO3-
NO2 concentrations (38). In this sense, it may be speculated
that the effects of leptin on the control of vascular tone may
arise from two different sources. On the one hand, leptin
present in the vascular lumen and, on the other hand, leptin
released from perivascular adipocytes may participate in
regulation of contraction of the vascular wall.
The lack of effect of leptin on vascular preparations from
Zucker rats provides a potential mechanistic explanation for
obesity-associated hypertension, i.e. the loss of antagonism of
ANG II-mediated vasoconstriction. Two arguments add sup-
port to this possibility: 1) obesity-associated hypertension is
characterized by both leptin resistance (19) and stimulation
of the renin-angiotensin system (13); and 2) exaggerated va-
soconstriction (39) and prolonged VSMC [Ca2]i exposure
(40) to ANG II have been reported in Zucker rats.
In conclusion, our results provide additional evidence that
OB-Rb are expressed in VSMCs from the aorta of Wistar rats
and, therefore, represent a target for leptin action. Our find-
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ings indicate that leptin inhibits ANG II-mediated vasocon-
striction by blocking the release of Ca2 from VSMC intra-
cellular stores. The lack of effect of leptin on ANG II-
mediated effects of vascular preparations obtained from
leptin receptor-deficient Zucker rats suggests that OB-Rb are
functional in the vascular wall of Wistar rats. Further studies
are required to elucidate the pathophysiological relevance of
this new vascular action of leptin in human obesity-associ-
ated arterial hypertension.
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